PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8+ T cells in breast cancer
-
Published:2022-04
Issue:
Volume:531
Page:98-108
-
ISSN:0304-3835
-
Container-title:Cancer Letters
-
language:en
-
Short-container-title:Cancer Letters
Author:
Chaib MehdiORCID,
Sipe Laura M.ORCID,
Yarbro Johnathan R.,
Bohm Margaret S.ORCID,
Counts Brittany R.,
Tanveer Ubaid,
Pingili Ajeeth K.,
Daria Deidre,
Marion Tony N.ORCID,
Carson James A.,
Thomas Paul G.ORCID,
Makowski LizaORCID
Subject
Cancer Research,Oncology
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献